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Acetylsalicylic acid (ASA) is a nonsteroidal anti-inflam-
matory drug that can cause mast cell dependent diseases
in sensitive individuals. ASA induced asthma is believed
to be related to an overproduction of cysteinyl leuko-
triene C4 (LTC4) secondary to cyclooxygenase inhibi-
tion. It remains to be elucidated whether and by which
mechanisms ASA may also influence systemic anaphy-
lactic reactions.
In order to clarify if ASA modulates passive systemic
anaphylaxis (PSA), Balb/c mice were pre-treated with
ASA, sensitized with anti-TNP-BSA intravenously fol-
lowed by intravenous challenge with TNP-BSA. The
temperature profile was assessed for 70 min. Levels of
mast cell mediators in the sera (histamine, serotonin,
LTC4) were determined by ELISA. Additionally murine
bone marrow-derived cultured and peritoneal mast cells
were incubated in vitro with ASA, loaded with IgE, sti-
mulated with anti-IgE and histamine release was
assessed.
ASA aggravated the symptoms of PSA; the maximum
temperature drop for ASA pre-treated mice was 5.1 ±
0.4 versus 3.7 ± 0.5 in the control (p = 0.004). In line
with exacerbated hypothermia, elevated amounts of
mast cell mediators were found in mouse sera. LTC4
was enhanced and most interestingly, increases in the
preformed mediators histamine and serotonin were like-
wise detected. Contrary to these findings the histamine
release of mast cells incubated with ASA in vitro was
reduced.
Together, ASA potentiates PSA probably by enhancing
the degranulation of mast cells in vivo, thereby increas-
ing the availability of anaphylactic mediators. Since ASA
suppresses mast cell activation in vitro, the environment
surrounding the mast cells dictate most likely changes
in the releasability of these effector cells upon ASA
treatment. Our findings emphasize the importance of in
vivo models to study anaphylaxis as only in vivo experi-
ments can unravel the complex interplay of different
cells and tissue factors.
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